Stay updated with breaking news from Regulatory Activities. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Statin therapy modestly increases diabetes diagnoses but offers substantial cardiovascular benefits, outweighing the slight rise in glycemia, especially in those near diabetes diagnostic thresholds.
This phase 2 randomized trial examines the antihypertensive efficacy and safety of different zilebesiran dosing regimens.
/PRNewswire/ -- Pierre Fabre Laboratories announced today an expanded global partnership with Atara Biotherapeutics, a leader in T-cell immunotherapy,...
This open-label, single-group, phase 3 trial evaluates eplontersen, an investigational ligand-conjugated antisense oligonucleotide, in adults with hereditary am